Fundraising Fox

Biotech Growth Investors & VC Firms

747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Octopus Ventures
LondonPre-Seed–Late Stage$130K – $1.3M
87 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
71 people
Speedinvest
ViennaPre-Seed–Late Stage$5M – $30M
81 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
78 people
Paladin Capital Group
WashingtonSeed–Late Stage$100K – $5M
73 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
49 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
75 people
Portfolia
San MateoSeed–Late Stage
58 people
ARCH Venture Partners
ChicagoSeed–Growth$50K – $250M
43 people
IMM Investment Japan
SeoulSeed–Late Stage
21 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Future Planet Capital
LondonSeed–Late Stage
34 people
Elaia
ParisSeed–Growth$108K – $1.6M
51 people
Deerfield Management Company
New YorkGrowth–Late Stage
88 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
29 people
Innovestor Ventures
HelsinkiPre-Seed–Growth$270K – $3.2M
29 people
Thompson Street Capital Partners
St. LouisGrowth–Late Stage$50M – $500M
66 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
28 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
78 people
B Capital Group
Manhattan BeachSeed–Late Stage$100K – $60M
38 people
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
25 people
Ampersand
BostonGrowth
61 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
48 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.